Exploring the relationship between bulk Young ' s Modulus of materials and milling efficiency during wet bead milling of pharmaceutical compounds

被引:3
作者
Salahshoor, Zahra [1 ]
Desai, Parind M. [1 ]
Chattoraj, Sayantan [1 ]
Lam, Stephanie [2 ]
机构
[1] GlaxoSmithKline Res & Dev Ltd, Drug Prod Dev, Med Dev & Supply, Philadelphia, PA USA
[2] GlaxoSmithKline Res & Dev Ltd, Drug Subst Dev, Med Dev & Supply, Philadelphia, PA USA
关键词
Materials Science Tetrahedron (MST); Manufacturing; Wet Bead Milling; Young's Modulus; Material Sparing Approach; Long Acting Injectables (LAIs); IN-VIVO CORRELATION; NANOSUSPENSIONS; INDENTATION; DELIVERY;
D O I
10.1016/j.ijpharm.2024.124365
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Wet bead milling (WBM) is one of the main approaches for manufacturing long acting injectable (LAI) suspensions, wherein the particle size of an Active Pharmaceutical Ingredient (API) is reduced in a liquid vehicle via grinding. A common challenge observed during WBM is long milling time to achieve target particle size, resulting in poor milling efficiency. The objective of this work was to identify potential API attributes predictive of milling efficiency during WBM. In this study, physical and mechanical properties of nine APIs were characterized. Formulations with these APIs were manufactured using WBM. Bulk Young 's Modulus was identified to have a significant influence on the rate of particle attrition. The rank order of Young 's Moduli of the APIs was consistent with that of milling efficiency, estimated by an empirical function defined in this study called Milling Resistance ( phi), representing the holistic impact of milling time, tip speed, bead loading, and batch to chamber volume ratio. The identification of such intrinsic material properties, which provide an early evaluation of potential manufacturing risks, is beneficial to product development, as these assessments can be performed with limited quantities of materials and help identify and design out scale-up challenges.
引用
收藏
页数:8
相关论文
共 46 条
[1]   Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres [J].
Andhariya, Janki V. ;
Shen, Jie ;
Choi, Stephanie ;
Wang, Yan ;
Zou, Yuan ;
Burgess, Diane J. .
JOURNAL OF CONTROLLED RELEASE, 2017, 255 :27-35
[2]   Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group [J].
Bauer, Andrea ;
Berben, Philippe ;
Chakravarthi, Sudhir S. ;
Chattorraj, Sayantan ;
Garg, Ashish ;
Gourdon, Betty ;
Heimbach, Tycho ;
Huang, Ye ;
Morrison, Christopher ;
Mundhra, Deepak ;
Palaparthy, Ramesh ;
Saha, Pratik ;
Siemons, Maxime ;
Shaik, Naveed A. ;
Shi, Yi ;
Shum, Sara ;
Thakral, Naveen K. ;
Urva, Shweta ;
Vargo, Ryan ;
Koganti, Venkat R. ;
Barrett, Stephanie E. .
PHARMACEUTICAL RESEARCH, 2023, 40 (07) :1601-1631
[3]   THE DEVELOPMENT OF A COMMINUTION INDEX FOR ROCK AND THE USE OF AN EXPERT SYSTEM TO ASSIST THE ENGINEER IN PREDICTING CRUSHING REQUIREMENTS [J].
BEARMAN, RA ;
BARLEY, RW ;
HITCHCOCK, A .
MINERALS ENGINEERING, 1990, 3 (1-2) :117-127
[4]   Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions [J].
Bilgili, E. ;
Guner, G. .
AAPS PHARMSCITECH, 2021, 22 (01)
[5]  
Bilgili E., 2020, 1 INT EL C PHARM
[6]   Design Space and Control Strategy for the Manufacturing of Wet Media Milled Drug Nanocrystal Suspensions by Adopting Mechanistic Process Modeling [J].
Bitterlich, Andre ;
Mihorko, Andrej ;
Juhnke, Michael .
PHARMACEUTICS, 2024, 16 (03)
[7]   Transition from Amorphous Cyclosporin A Nanoparticles to Size-Reduced Stable Nanocrystals in a Poloxamer 407 Solution [J].
Chen, Ziqiao ;
Higashi, Kenjirou ;
Ueda, Keisuke ;
Moribe, Kunikazu .
MOLECULAR PHARMACEUTICS, 2022, 19 (01) :188-199
[8]   Development of a Semi-Mechanistic Modeling Framework for Wet Bead Milling of Pharmaceutical Nanosuspensions [J].
Clancy, Donald J. ;
Guner, Gulenay ;
Chattoraj, Sayantan ;
Yao, Helen ;
Faith, M. Connor ;
Salahshoor, Zahra ;
Martin, Kailey N. ;
Bilgili, Ecevit .
PHARMACEUTICS, 2024, 16 (03)
[9]   Engineering Size and Structure of Particles in Novel Modified-Release Delivery Systems [J].
Dong, Qianqian ;
Zheng, Xiao ;
Zhou, Miaomiao ;
Wu, Fei ;
Hong, Yanlong ;
Lin, Xiao ;
Shen, Lan .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2019, 22 :150-170
[10]  
Downs R. R., 2015, 41 INT ASS SOC SCI I